- ￥600 - 3200
- 上海莼试
- CS-01Y65456
- 国产
- 2025年10月07日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 库存：
32
- 英文名：
Casein Kinase inhibitor A51
- CAS号：
2079068-74-7
- 供应商：
上海莼试
- 保存条件：
Store at -20°C
- 规格：
5 mg
分子式:C18H25ClN6
分子量:360.88
溶解度:N/A
储存条件:Store at -20°C
General tips:For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping Condition:Evaluation sample solution : ship with blue ice All other available size: ship with RT , or blue ice upon request
Similar to CKIα depletion, Casein Kinase inhibitor A51 (0.05-3.2 μM; 18 hours) treatment of RKO cells abolished most of the Ser45 phosphorylation signal and the consecutive GSK3 phosphorylation cascade resulting in stabilization of β-catenin[1]. Casein Kinase inhibitor A51 is highly effective in inducing leukemia cell apoptosis at 160 nM or lower, mostly in correlation to their capacity to stabilize p53[1].Casein Kinase inhibitor A51 (0.08-2 μM; 6.5 hours) abolishes the expression of MYC, MDM2, and the anti-apoptotic oncogene MCL1. Casein Kinase inhibitor A51 induces a marked reduction in mRNA expression of MYC and MDM2, yet upregulates the expression of the Wnt targets AXIN2 and CCND1 (Cyclin D1)[1].Oral treatment is initiated at 8 days (Casein Kinase inhibitor A51; 5 mg/kg/day) after leukemia cell inoculation, at which the percentage of leukemia cells in the BM is more than 1.5% of all cells. all A51-treated mice have normal organ morphology and histology and normal blood counts[1].Pharmacokinetic studies of the inhibitor Casein Kinase inhibitor A51 at 20 mg/kg reveal rapid oral absorption with a Tmax of 0.5-2 hr, Cmax of 1060 ng/mL, T1/2 of 2.5 hr, and area under the curve (AUC) values of 3680 (ng*hr/mL)[1].[1]. Waleed Minzel, et al. Small Molecules Co-targeting CKIα and the Transcriptional Kinases CDK7/9 Control AML in Preclinical Models. Cell. 2018 Sep 20;175(1):171-185.e25..
商品属性：
| 货号 | CS-01Y65456 | 规格 | 5 mg |
| CAS号 | 2079068-74-7 | 分子量 | 360.88 |
| 含量 | >98.00% | 别名 | N/A |
| 分子式 | C18H25ClN6 | 化学名 | N/A |
| 产地 | 国产 | 用途 | 仅供科研研究实验 |
抗逆滴加序列
每次向板内滴加抗原时，移液器滴头要与平面45度悬空，不要触碰到孔内的液体，由后向前依次滴加(即浓度由低往高滴加)。
抗感染反应期
抗原抗体在室温20~25℃下，必须反应30min以上，若环境温度低于室温，可将微量反应板置于恒温培养箱中，使二者充分反应。
旅游温度
磷酸盐缓冲液的pH值要在高压灭菌后进行滴定，往往在高压后pH值会有所改变，所以高压后再调一次pH值更为准确。磷酸盐缓冲液一经使用保存期不要超过3周。当pH<5.8时，红细胞会产生自凝现象;当pH>7.8时，图形洗脱加快，易造成肉眼观察产生误差;p H=7.2时，红细胞沉降最充分，图形最清晰。
当滴注 1%红细胞悬液时，应经常摇晃红细胞悬液，使红细胞均匀地分布在磷酸缓冲液中，以防止红细胞下降。
反应时间及温度
加入鸡红血球之后，反应板在室温(20~25℃)静置30~40min，对照孔血球下沉于孔底，即可判定结果。若室温达不到实验要求，需相应调整反应时间。当环境温度低于4℃时，红细胞发生自凝;高于37℃时，会发生反应物分离和红细胞溶血。
公司正在出售的产品：
| Recombnant Human ACADM | 鸟嘌呤核苷酸交换因子VAV3封闭多肽 |
| 胞质接头蛋白Keap1封闭多肽 | phospho-RAD9A (Ser272) Antibody Blocking Peptide |
| G蛋白通路抑制物蛋白2封闭多肽 | SZT2 Antibody Blocking Peptide |
| 中心体蛋白CEP170封闭多肽 | BTBD1 Antibody Blocking Peptide |
| 磷酸化谷氨酸受体1封闭多肽 | CNR-2 Antibody Blocking Peptide |
| 含脯氨酸突触相关蛋白相互作用蛋白1封闭多肽 | OLR1 Antibody Blocking Peptide |
| RAS的GTP酶激活蛋白封闭多肽 | MRGPRH Antibody Blocking Peptide |
| 重组人GUCY2C蛋白 | GTP酶MAP家族成员2封闭多肽 |
| 磷酸化细胞周期检查控制蛋白质封闭多肽 | Recombinant human GUCY2C protein, C-His-Avi (HEK293) |
| 1号染色体开放阅读框84封闭多肽 | RASA2 Antibody Blocking Peptide |
| 钙粘蛋白相关的神经受体2封闭多肽 | ProSAPiP1 Antibody Blocking Peptide |
| 丙肝病毒NS5A反转录蛋白8封闭多肽 | phospho-GRIA1 (Ser645) Antibody Blocking Peptide |
| 凝集素样氧化型低密度脂蛋白受体封闭多肽 | Casein Kinase inhibitor A51CEP170 Antibody Blocking Peptide |
| MRGPRH蛋白封闭多肽 | GPS2 Antibody Blocking Peptide |
| VAV3 Antibody Blocking Peptide | KEAP1 Antibody Blocking Peptide |
1.本蛋白酶抑制剂混合物为100×的储存液，使用时按照1:100的比例加入到裂解液中(例如，1ml裂解液中加入10μl蛋白酶抑制剂混合物)，混匀后即可使用。根据需要，0.5M的EDTA也按照1:100的比例加入到裂解液中（如用于检测金属蛋白酶活性，则不宜添加EDTA）。含有蛋白酶抑制剂混合物的裂解液宜现用现配，不宜配制后冻存待后续使用。
2. 待所需的抑制剂添加完毕混匀后，就可以开始进行哺乳动物组织的裂解和蛋白提取。
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Kinase Inhibitor Profiling Using Chemoproteomics
Quantitative chemoproteomics has recently emerged as an experimental approach to determine protein interaction profiles of small molecules in a given cell line or tissue. In contrast to standard biochemical and biophysical kinase assays
Kinase Inhibitor Selectivity Profiling Using Differential Scanning Fluorimetry
and widely used approach is the direct measurement of the effect of the added ligands on its activity. A variety of enzymatic assay formats have been successfully applied for inhibitor screening of protein kinases. However, enzymatic assays require an active
Receptor Tyrosine Kinase Inhibitor Profiling Using Bead-Based Multiplex Sandwich Immunoassays
) as an example. We provide a protocol for a bead-based sandwich immunoassay that enables a relative quantification of the EGFR and its generic tyrosine phosphorylation. We also present data from a kinase inhibitor experiment using 96-well cell-culture plates
技术资料暂无技术资料 索取技术资料
